Researchers have eliminated caged mosquitoes using ‘gene drive’ technology to spread a genetic modification that blocks female reproduction.
The team from Imperial College London were able to crash caged populations of the malaria vector mosquito Anopheles gambiae in only 7-11 generations.
This breakthrough shows that gene drive can work, providing hope in the fight against a disease that has plagued mankind for centuries
Professor Andrea Crisanti | Lead researcher
This is the first time experiments have been able to completely block the reproductive capacity of a complex organism in the laboratory using a designer molecular approach.
The technique, called gene drive, was used to selectively target the specific mosquito species An. gambiae that is responsible for malaria transmission in sub-Saharan Africa. There are around 3500 species of mosquito worldwide, of which only 40 related species can carry malaria.
The hope is that mosquitoes carrying a gene drive would be released in the future, spreading female infertility within local malaria-carrying mosquito populations and causing them to collapse.
In 2016, there were around 216 million malaria cases and an estimated 445,000 deaths worldwide, mostly of children under five years old.
Lead researcher Professor Andrea Crisanti, from the Department of Life Sciences at Imperial, said: “2016 marked the first time in over two decades that malaria cases did not fall year-on-year despite huge efforts and resources, suggesting we need more tools in the fight.”
World first: Suppressing a population
The team’s results, published today in Nature Biotechnology, represent the first time gene drive has been able to completely suppress a population, overcoming resistance issues previous approaches have faced.
Professor Crisanti added: “This breakthrough shows that gene drive can work, providing hope in the fight against a disease that has plagued mankind for centuries. There is still more work to be done, both in terms of testing the technology in larger lab-based studies and working with affected countries to assess the feasibility of such an intervention.
“It will still be at least 5-10 years before we consider testing any mosquitoes with gene drive in the wild, but now we have some encouraging proof that we’re on the right path. Gene drive solutions have the potential one day to expedite malaria eradication by overcoming the barriers of logistics in resource-poor countries.”
Targeting ‘doublesex‘: About the research methodology
The team targeted a gene in An. gambiae called ‘doublesex‘, which determines whether an individual mosquito develops as a male or as a female.
The team engineered a gene drive solution designed to selectively alter a region of the doublesex gene that is responsible for female development. Males who carried this modified gene showed no changes, and neither did females with only one copy of the modified gene. However, females with two copies of the modified gene showed both male and female characteristics, failed to bite and did not lay eggs.
Their experiments showed that the gene drive transmitted the genetic modification nearly 100% of the time. After eight generations no females were produced and the populations collapsed because of lack of offspring.
Previous attempts to develop gene drive for population suppression have encountered ‘resistance’, where targeted genes developed mutations that allowed the gene to carry out its function, but that that were resistant to the drive. These changes would then be passed down to the offspring, halting the gene drive in its tracks.
One of the reasons doublesex was picked for the gene drive target was that it was thought not to tolerate any mutations, overcoming this potential source of resistance. Indeed, in the study no functional mutated copy of the doublesex gene arose and spread in the population.
Next steps: Investigating the efficacy
While this is the first time resistance has been overcome, the team say additional experiments are needed to investigate the efficacy and the stability of the gene drive under confined laboratory settings that mimic tropical environments.
This involves testing the technology on larger populations of mosquitoes confined in more realistic settings, where competition for food and other ecological factors may change the fate of the gene drive.
The doublesex gene targeted in the study is similar across the insect world, although different insects have different exact genetic sequences. This suggests the technology could be used in the future to specifically target other disease-carrying insects.
Recent work from Imperial showed that suppressing An. gambiaepopulations in local areas is unlikely to affect the local ecosystem.
The Latest on: Gene drive
The Latest on: Biomechanics
via Google News
The Latest on: Gene drive
- This Gene Technology Could Change the World. Its Maker Isn’t Sure It Should.on November 18, 2019 at 7:56 pm
Those same lives could potentially be saved with CRISPR-based gene drive—a technology that the evolutionary engineer conceptualized in 2013 and told the world about in 2014. When an organism sexually ...
- CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cureon November 18, 2019 at 4:27 pm
For more information, please visit www.excisionbio.com. Editor’s Note: Dr. Khalili is a named inventor on patents that cover the CRISPR/CAS9 system viral gene editing technology. In addition, Dr.
- This Meridian drive-in restaurant made famous by Clint Eastwood is set to closeon November 18, 2019 at 2:17 pm
Named for Clint Eastwood’s character in the 1980 movie, the burger — which Bronco Billy ate when he stopped there — is getting retired along with the drive-in restaurant itself ... “We’re sad to hear ...
- Gene therapy: Development of new DNA transporterson November 18, 2019 at 7:59 am
Scientists at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed new delivery vehicles for future gene therapies. A team of researchers led by Dr. Christian ...
- Gene Test Might Someday Gauge Your Cardiac Arrest Riskon November 18, 2019 at 6:43 am
Researchers said they have identified a group of 14 gene variants that appear to be linked to sudden cardiac death. People carrying any of these variants had a more than triple the risk of dying from ...
- Axovant Gene Therapies Receives Orphan Drug Designation from FDA for AXO-AAV-GM1 for the Treatment of GM1 Gangliosidosison November 18, 2019 at 6:31 am
“We are pleased to receive orphan drug designation for our GM1 gangliosidosis program as we advance the development of this potentially transformative, one-time gene therapy,” said Dr. Gavin Corcoran, ...
- PTC Therapeutics Launches A No-Cost Testing Program to Drive AADC Deficiency Patient Identificationon November 18, 2019 at 4:00 am
AADC deficiency is caused by pathogenic mutations in the dopa decarboxylase (DDC) gene, resulting in a lack of functioning AADC enzyme ... and to ensure the best possible treatment," said Dr. Arndt ...
- Researchers discover new mutations in gene associated with disease that causes the heart to weakenon November 17, 2019 at 12:00 pm
"Currently, physicians don't routinely test patients with NIDC for all of these known and new TTN-tv gene mutations, and there's no specific genetic treatment for the disease," said Dr. Anderson.
- Rich Archbold: Gene Lentzer, although ailing at 97, keeps fighting for civil rightson November 15, 2019 at 3:00 pm
Gene Lentzner has been a fighter all his life against bias ... loved ones bid inseparable Long Beach icons George and Mama Rodou Loizides farewell Rich Archbold: “Let’s Play Ball” holiday drive to ...
via Bing News